Undifferentiated Carcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
HA-1 T TCR T Cell Immunotherapy for the Treating of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Conditions: Acute Biphenotypic Leukemia in Relapse (Diagnosis); Acute Undifferentiated Leukemia in Relapse (Diagnosis); HLA-A*0201 HA-1 Positive Cells Present; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Lympho blastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Refractory Childhood Acute Lymphoblastic Leukemia; Refractory Childhood Acute Myeloid Leukemia Interventions: Drug: Fludarabine Phosph...
Source: ClinicalTrials.gov - October 31, 2017 Category: Research Source Type: clinical trials